Table 1.
Demographic and Clinical Characteristics of the Study Population
| Post-TB Bronchiectasis (n=129) |
Idiopathic Bronchiectasis (n=76) |
Other Bronchiectasis (n=96) |
|
|---|---|---|---|
| Age, years | 68±11*‡ | 54±17 | 52±19 |
| Gender, female | 79(61%) | 55(72%) | 66(69%) |
| BMI, kg/m2 | 27±7.5 | 27.7±7.7 | 28.2±7.4 |
| Smoker/ex-smoker | 10(6.7%) | 6(7.9%) | 6(6.3%) |
| MRC dyspnea score | 2.8 ±1.0*‡ | 2.4 ±1.2 | 2.3 ±1.1 |
| FEV1% predicted | 62±17.7‡ | 67±19.7 | 69±24.1 |
| Pseudomonas aeruginosa colonization | 33(26%)* | 32(42%)‡ | 22(23%) |
| Other organisms colonization | 32(25%) | 24(32%) | 31(32%) |
| Polymicrobial colonization | 12(9%) | 14(18%) | 12(13%) |
| Number of acute exacerbations previous year | 2.8 ±2.9‡ | 2.5 ±3.9 | 1.7 ±2.3 |
| Previous hospitalization | 67(52%)*‡ | 22(30%) | 29(30%) |
| Radiologic extension in HRCT chest (Number of lobes) | 3.1 ±1.0*‡ | 3.7 ±0.89 | 2.6 ±1.2 |
| Cystic bronchiectasis | 96(74%)‡ | 56(74%) | 47(49%) |
| Severity Score | |||
| BSI | 10.5 ±2.5*‡ | 8.1 ±1.9 | 6.97 ±1.9 |
| BSI (mild/moderate/severe), % | 12/28/60*‡ | 36/32/32 | 47/19/34 |
| FACED | 3.8 ±2.1*‡ | 2.7 ±1.7 | 2.4 ±1.5 |
| FACED (mild/moderate/severe), % | 26/38/36*‡ | 55/24/21 | 60/27/13 |
| Exa-FACED | 4.4 ±2.3*‡ | 3.1 ±1.8 | 2.8 ±1.7 |
| Exa-FACED (mild/moderate/severe), % | 21/28/51*‡ | 51/21/28 | 53/25/22 |
| E-FACED | 4.8 ±1.8*‡ | 3.1 ±1.5 | 2.7 ±1.4 |
| E-FACED (mild/moderate/severe), % | 36/44/20*‡ | 62/22/16 | 66/27/7 |
Notes: *P<0.05 compared with Idiopathic bronchiectasis. ‡P<0.05 compared with other bronchiectasis.
Abbreviations: BMI, body mass index; FEV1%, forced expiratory volume-one second; MRC, Medical Research Council; HRCT, high resolution computed tomography; BSI, Bronchiectasis Severity Index; Exa-FACED and E-FACED, Exacerbation (FACED).